L. Curylova, H. Ramos, L. Saraiva, J. Skoda, Noncanonical roles of p53 in cancer stemness and their implications in sarcomas. Cancer Lett. 525, 131 (2022)

Article  CAS  PubMed  Google Scholar 

E. Thoenen, A. Curl, T. Iwakuma, TP53 in bone and soft tissue sarcomas. Pharmacol. Ther. 202, 149 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Skoda, R. Veselska, Cancer stem cells in sarcomas: getting to the stemness core. Biochim. Biophys. Acta Gen. Subj. 1862, 2134 (2018)

Article  CAS  PubMed  Google Scholar 

S.M. Perkins, E.T. Shinohara, T. DeWees, H. Frangoul, Outcome for children with metastatic solid tumors over the last four decades. PloS One. 9, e100396 (2014)

Article  PubMed  PubMed Central  Google Scholar 

V. Tirino, V. Desiderio, R. d’Aquino, F. De Francesco, G. Pirozzi, A. Graziano, U. Galderisi, C. Cavaliere, A. De Rosa, G. Papaccio, A. Giordano, Detection and characterization of CD133 + cancer stem cells in human solid tumours. PloS One. 3, e3469 (2008)

Article  PubMed  PubMed Central  Google Scholar 

M.-L. Suvà, N. Riggi, J.-C. Stehle, K. Baumer, S. Tercier, J.-M. Joseph, D. Suvà, V. Clément, P. Provero, L. Cironi, M.-C. Osterheld, L. Guillou, I. Stamenkovic, Identification of cancer stem cells in Ewing’s sarcoma. Cancer Res. 69, 1776 (2009)

Article  PubMed  Google Scholar 

L. Wang, P. Park, H. Zhang, F.L. Marca, C.-Y. Lin, Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int. J. Cancer. 128, 294 (2011)

Article  CAS  PubMed  Google Scholar 

J.-C. Yeo, H.-H. Ng, The transcriptional regulation of pluripotency. Cell. Res. 23, 20 (2013)

Article  CAS  PubMed  Google Scholar 

J. Skoda, A. Nunukova, T. Loja, I. Zambo, J. Neradil, P. Mudry, K. Zitterbart, M. Hermanova, A. Hampl, J. Sterba, R. Veselska, Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Tumour Biol. 37, 9535 (2016)

Article  CAS  PubMed  Google Scholar 

G. Maurizi, N. Verma, A. Gadi, A. Mansukhani, C. Basilico, Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma. Oncogene. 37, 4626 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

K.C. Genadry, S. Pietrobono, R. Rota, C.M. Linardic, Soft tissue sarcoma cancer stem cells. Overv. Front. Oncol. 8, 475 (2018)

C.N. Amaya, B.A. Bryan, Enrichment of the embryonic stem cell reprogramming factors Oct4, nanog, Myc, and Sox2 in benign and malignant vascular tumors. BMC Clin. Pathol. 15, 18 (2015)

Article  PubMed  PubMed Central  Google Scholar 

S.R. Martins-Neves, W.E. Corver, D.I. Paiva-Oliveira, B.E.W.M. van den Akker, I.H. Briaire-de-Bruijn, J.V.M.G. Bovée, C.M.F. Gomes, A.-M. Cleton-Jansen, Osteosarcoma Stem cells have active Wnt/β-catenin and overexpress SOX2 and KLF4. J. Cell. Physiol. 231, 876 (2016)

Article  CAS  PubMed  Google Scholar 

A. Huyghe, A. Trajkova, F. Lavial, Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective. Trends Cell. Biol. S0962 (2023)

D.J. Olivos, L.D. Mayo, Emerging non-canonical functions and regulation by p53: p53 and Stemness. Int. J. Mol. Sci. 17, (2016)

P. Kameneva, V.I. Melnikova, M.E. Kastriti, A. Kurtova, E. Kryukov, A. Murtazina, L. Faure, I. Poverennaya, A.V. Artemov, T.S. Kalinina, N.V. Kudryashov, M. Bader, J. Skoda, P. Chlapek, L. Curylova, L. Sourada, J. Neradil, M. Tesarova, M. Pasqualetti, P. Gaspar, V.D. Yakushov, B.I. Sheftel, T. Zikmund, J. Kaiser, K. Fried, N. Alenina, E.E. Voronezhskaya, I. Adameyko, Serotonin limits generation of chromaffin cells during adrenal organ development. Nat. Commun. 13, 2901 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B. Leroy, M.L. Ballinger, F. Baran-Marszak, G.L. Bond, A. Braithwaite, N. Concin, L.A. Donehower, W.S. El-Deiry, P. Fenaux, G. Gaidano, A. Langerød, E. Hellstrom-Lindberg, R. Iggo, J. Lehmann-Che, P.L. Mai, D. Malkin, U.M. Moll, J.N. Myers, K.E. Nichols, S. Pospisilova, P. Ashton-Prolla, D. Rossi, S.A. Savage, L.C. Strong, P.N. Tonin, R. Zeillinger, T. Zenz, J.F. Fraumeni, P.E.M. Taschner, P. Hainaut, T. Soussi, Recommended guidelines for Validation, Quality Control, and reporting of TP53 variants in clinical practice. Cancer Res. 77, 1250 (2017)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Malcikova, S. Pavlova, B. Kunt Vonkova, L. Radova, K. Plevova, J. Kotaskova, K. Pal, B. Dvorackova, M. Zenatova, J. Hynst, E. Ondrouskova, A. Panovska, Y. Brychtova, K. Zavacka, B. Tichy, N. Tom, J. Mayer, M. Doubek, S. Pospisilova, Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 138, 2670 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Hu, G.K. Smyth, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods. 347, 70 (2009)

Article  CAS  PubMed  Google Scholar 

P. Bankhead, M.B. Loughrey, J.A. Fernández, Y. Dombrowski, D.G. McArt, P.D. Dunne, S. McQuaid, R.T. Gray, L.J. Murray, H.G. Coleman, J.A. James, M. Salto-Tellez, P.W. Hamilton, QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017)

Article  PubMed  PubMed Central  Google Scholar 

J.D. Lathia, H. Liu, Overview of cancer stem cells and stemness for community oncologists. Target. Oncol. 12, 387 (2017)

Article  PubMed  PubMed Central  Google Scholar 

E. Halachmi, I.P. Witz, Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity. Cancer Res. 49, 2383 (1989)

CAS  PubMed  Google Scholar 

B. Graves, T. Thompson, M. Xia, C. Janson, C. Lukacs, D. Deo, P. Di Lello, D. Fry, C. Garvie, K.-S. Huang, L. Gao, C. Tovar, A. Lovey, J. Wanner, L.T. Vassilev, Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization. Proc. Natl. Acad. Sci. U. S. A. 109, 11788 (2012)

V.J.N. Bykov, N. Zache, H. Stridh, J. Westman, J. Bergman, G. Selivanova, K.G. Wiman, PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis. Oncogene. 24, 3484 (2005)

Article  CAS  PubMed  Google Scholar 

S. Jamil, I. Lam, M. Majd, S.-H. Tsai, V. Duronio, Etoposide induces cell death via mitochondrial-dependent actions of p53. Cancer Cell. Int. 15, 79 (2015)

Article  PubMed  PubMed Central  Google Scholar 

A. Montecucco, F. Zanetta, G. Biamonti, Molecular mechanisms of etoposide. EXCLI J. 14, 95 (2015)

PubMed  PubMed Central  Google Scholar 

G. Sannino, A. Marchetto, A. Ranft, S. Jabar, C. Zacherl, R. Alba-Rubio, S. Stein, F.S. Wehweck, M.M. Kiran, T.L.B. Hölting, J. Musa, L. Romero-Pérez, F. Cidre-Aranaz, M.M.L. Knott, J. Li, H. Jürgens, A. Sastre, J. Alonso, W. Da Silveira, G. Hardiman, J.S. Gerke, M.F. Orth, W. Hartmann, T. Kirchner, S. Ohmura, U. Dirksen, T.G.P. Grünewald, Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in ewing sarcoma patients. EBioMedicine. 47, 156 (2019)

Article  PubMed  PubMed Central  Google Scholar 

U. Basu-Roy, E. Seo, L. Ramanathapuram, T.B. Rapp, J.A. Perry, S.H. Orkin, A. Mansukhani, C. Basilico, Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene. 31, 2270 (2012)

Article  CAS  PubMed  Google Scholar 

S.T. Menendez, V. Rey, L. Martinez-Cruzado, M.V. Gonzalez, A. Morales-Molina, L. Santos, V. Blanco, C. Alvarez, O. Estupiñan, E. Allonca, J.P. Rodrigo, J. García-Castro, J.M. Garcia-Pedrero, R. Rodriguez, SOX2 expression and transcriptional activity identifies a subpopulation of Cancer Stem cells in Sarcoma with prognostic implications. Cancers. 12, 964 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Walter, S. Satheesha, P. Albrecht, B.C. Bornhauser, V. D’Alessandro, S.M. Oesch, H. Rehrauer, I. Leuschner, E. Koscielniak, C. Gengler, H. Moch, M. Bernasconi, F.K. Niggli, B.W. Schäfer, and CWS Study Group, CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PloS One. 6, e19506 (2011)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Aloni-Grinstein, Y. Shetzer, T. Kaufman, V. Rotter, p53: the barrier to cancer stem cell formation. FEBS Lett. 588, 2580 (2014)

Article  CAS  PubMed  Google Scholar 

W.D. Pontius, E.S. Hong, Z.J. Faber, J. Gray, C.D. Peacock, I. Bayles, K. Lovrenert, D.H. Chin, B.E. Gryder, C.F. Bartels, P.C. Scacheri, Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis. Nat. Commun. 14, 7209 (2023)

Article